The use of glutathione in cosmetics is growing, but with stricter claims validation compared to Asia
But Susan Wolver, M.D., medical director of the VCU Health Medical Weight Loss Program, warns that this treatment isnt for everyone, because once you are on a GLP-1, there is a high probability of gaining weight back after going off them
Therefore, it is crucial to approach IV glutathione therapy under the guidance of a qualified healthcare professional who can monitor its effects and adjust dosages as necessary
Some GLP-1 drugs like semaglutide have now been approved for adolescents aged 12 and over for obesity treatment
Many such agents are under investigation
A spokesperson for the company noted that gastroparesis is a known risk for people with diabetes and that "patient safety is of utmost importance to Novo Nordisk." Gastroparesis is not mentioned in the prescribing information for Ozempic or Wegovy, but delayed gastric emptying is mentioned for each drug